[The concept of innovative drugs is active, Jinshi Yao has a daily limit of 20CM] On September 17, the concept of innovative drugs is active, Jinshi Yao has a daily limit of 20CM, and New Ganjiang, Frontier Biotech, Haixiang Pharmaceutical, and Wanbang Pharmaceutical have followed suit. In terms of news, it is reported that since the beginning of this year, China’s innovative drugs have accelerated their pace of exporting overseas, with the total number of external licensing transactions exceeding US$120 billion, a year-on-year increase of 36%. Among them, the scale of down payment exceeds 10 billion US dollars, and the market also shows the characteristics of steady growth in the average transaction amount, both the amount and proportion of down payment, and the frequent implementation of large-value transactions.